Latest Updates
News
Peptide research updates, regulatory changes, and industry developments.
April 16, 2026
FDA Moves to Restore Peptide Access — What Researchers Need to Know
The FDA posted a Federal Register notice considering lifting restrictions on seven Category 2 peptides, with an advisory panel scheduled for late July 2026. Here’s what it means for the research community.
Read more →April 12, 2026
RFK’s Peptide Ruling: Where Things Stand in April 2026
RFK Jr. announced 14 peptides would return to legal compounding status — but the FDA hasn’t published the official list yet. Here’s what we know, what’s still pending, and what it means for researchers.
Read more →April 10, 2026
RFK Jr. Announces 14 Peptides Coming Off FDA Restricted List
HHS Secretary Robert F. Kennedy Jr. announced that 14 of 19 previously restricted peptides will be moved off the FDA’s “do not compound” list — the largest regulatory reversal in U.S. peptide history.
Read more →